What is the Thyrocare Technologies Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 9.37% of the total equity shares of Thyrocare Technologies Ltd.

What is the Thyrocare Technologies Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 25.92% of the total equity shares of Thyrocare Technologies Ltd.

How has the Thyrocare Technologies Ltd promoter holding changed?

The promoter holding in Thyrocare Technologies Ltd changed from 60.92% to 51.02% during the latest reported period.

How has the Thyrocare Technologies Ltd FII holding changed?

The FII holding in Thyrocare Technologies Ltd changed from 5.44% to 9.37% during the latest reported period.

How has the Thyrocare Technologies Ltd DII holding changed?

The DII holding in Thyrocare Technologies Ltd changed from 20.92% to 25.92% during the latest reported period.

Who are the major shareholders of Thyrocare Technologies Ltd?

The major shareholders of Thyrocare Technologies Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Thyrocare Technologies Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Thyrocare Technologies Ltd public shareholding?

Public shareholders hold 13.70% of the total equity shares of Thyrocare Technologies Ltd as per the latest available data.

Thyrocare Technologies Ltd Share Price

Detail Overview

Diagnostic ServicesNSE

₹463.15

-8.95(-1.90%)

As on 23 Oct 2026 at 15:59

As of 23 Oct 2026 at 15:59, Thyrocare Technologies Ltd is trading at ₹463.15. The 52-week range stands at ₹342.55–₹662.00, with a market cap of ₹7.36 thousand crore. At a P/E of 44.02 and a dividend yield of 3.03%, it is a mid-cap stock in the Healthcare sector.